Source: Medical Design and Outsourcing

Axoft: Axoft makes Fleuron BCI material available for purchase, inks license deal with Stanford

Axoft announced today that it made its Fleuron ultra-soft brain implant material available for purchase for R&D applications. Cambridge, Massachusetts-based Axoft designed its novel Fleuron material for use in implantable brain-computer interfaces (iBCIs). Fleuron, which is 10,000 times softer than the polyimide material used in existing iBCIs, the company says, offering superior biocompatibility while reducing...The post Axoft makes Fleuron BCI material available for purchase, inks license deal with Stanford appeared first on Medical Design and Outsourcing.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Paul Le Floch's photo - Co-Founder & CEO of Axoft

Co-Founder & CEO

Paul Le Floch

CEO Approval Rating

90/100

Read more